Terrigal, NSW, Australia
OMERACT (Outcome Measures in Rheumatology) is an independent initiative of international health professionals interested in outcome measures in rheumatology. Through a data driven multi-stakeholder consensus process, OMERACT strives to identify and improve relevant health outcome domains, endorsing valid, responsive, feasible health outcome measures in patients with musculoskeletal conditions. An important aspect of OMERACT is the integration of patients at each stage of the OMERACT process. This patient input along with clinical trialist insight, epidemiologist assessment, and industry perspective, has led OMERACT to be a unique decision making group in developing outcome measures for all types of clinical trials and observational research. Consensus conferences take place every two years, with locations alternating between North America, Europe, and Asia-Pacific.
The 11th International Congress on Autoimmunity is the only meeting where you can learn about more than 80 autoimmune diseases from a variety of perspectives, both research-based and clinical. We will discuss the newest therapeutic techniques and diagnostic tools as well as the most up-to-date research on genetic, etiology, diagnostic, clinical aspects and novel therapies of autoimmune diseases. Established by Professor Yehuda Shoenfeld, this autoimmunity congress constitutes a network of international leaders on immunology, rheumatology and related fields, all of whom contribute their unique and diverse knowledge to the “family of autoimmunity.”
And for the first time in 2018 we will introduce the Academy of Autoimmunity, a systematic course on autoimmune diseases.